{"id":2729,"date":"2026-09-24T18:35:50","date_gmt":"2026-09-24T18:35:50","guid":{"rendered":"https:\/\/admarebio.com\/news-events\/news-insights\/"},"modified":"2026-09-24T18:35:50","modified_gmt":"2026-09-24T18:35:50","slug":"admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute","status":"publish","type":"post","link":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/","title":{"rendered":"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0"},"content":{"rendered":"\n<p><em>Twenty-two leaders from across Canada\u2019s life sciences sector join adMare\u2019s flagship leadership development program to strengthen the leadership pipeline driving company creation and growth.&nbsp;<\/em><\/p>\n\n\n\n<p><strong>Vancouver (BC), Toronto (ON), and Montreal (QC) \u2013 September 24, 2026&nbsp;<\/strong>\u2013 adMare BioInnovations (adMare) is pleased to welcome 22 participants to Cohort IX of the Executive Institute, the organization\u2019s flagship leadership program.&nbsp;&nbsp;Since its launch, the Executive Institute has helped develop 150 leaders from more than 100 organizations across Canada, strengthening the leadership pipeline and national networks needed to create, scale, and retain globally competitive companies.<\/p>\n\n\n\n<p>As Canada\u2019s life sciences company creation engine, adMare is focused on closing critical gaps across capital, infrastructure and talent to help build and scale a strong pipeline of investable Canadian life sciences companies. The Executive Institute is a key part of that effort, equipping participants with the tools, networks and perspectives needed to navigate growth, attract investment, build high-performing teams, and translate innovation into impact.<\/p>\n\n\n\n<p>\u201cCanada has the scientific excellence to build globally competitive life sciences companies, but success ultimately depends on people,\u201d said Matthew Carlyle, President and CEO of adMare Bioinnovations. \u201cThe calibre of this year\u2019s cohort reflects both the strength of Canada\u2019s life sciences sector and the growing recognition that leadership development is critical to translating scientific excellence into commercial success. We are proud to welcome these leaders and support them as they build the companies and organizations that will drive Canada\u2019s future growth and innovation.\u201d<\/p>\n\n\n\n<p>Selected from a highly competitive national applicant pool, Cohort IX brings together 22 accomplished leaders from across four provinces and every corner of Canada&#8217;s life sciences ecosystem. Participants represent a diverse range of organizations, roles and perspectives, including strong representation from women, racialized, 2SLGBTQI+, and official language minority communities.&nbsp;<\/p>\n\n\n\n<p>Through executive coaching, peer learning, and immersive workshops they will develop the leadership skills, trusted networks and practical insights to address real-time challenges of scaling innovative organizations and building globally competitive companies.<\/p>\n\n\n\n<p>Members of Cohort IX include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Julie Asselin<\/strong>\u00a0\u2013 Project Manager, Preclinical Affairs, Find Therapeutics\u00a0<\/li>\n\n\n\n<li><strong>Mike<\/strong>\u00a0<strong>Badeau\u00a0<\/strong>\u2013 President &amp; CEO, YYZ Pharmatech Inc.\u00a0<\/li>\n\n\n\n<li><strong>Stuart Barnscher<\/strong>\u00a0\u2013 Executive Director, Preclinical Programs, Zymeworks\u00a0<\/li>\n\n\n\n<li><strong>Meriem Benchabane<\/strong>\u00a0\u2013 VP, Strategic Development &amp; Operations, Feldan Therapeutics\u00a0<\/li>\n\n\n\n<li><strong>Mihai Burai-Patrascu<\/strong>\u00a0\u2013 Director, CADD, Molecular Forecaster Inc.\u00a0<\/li>\n\n\n\n<li><strong>Richard<\/strong>\u00a0<strong>Dean\u00a0<\/strong>\u2013 Senior Director, Biology, Xenon Pharmaceuticals\u00a0<\/li>\n\n\n\n<li><strong>Dominic Hou<\/strong>\u00a0\u2013 VP, Discovery, KisoJi Biotechnology Inc.\u00a0<\/li>\n\n\n\n<li><strong>Nicolette<\/strong>\u00a0<strong>Honson\u00a0<\/strong>\u2013 Director, Business Development, Borealis Biosciences\u00a0<\/li>\n\n\n\n<li><strong>Arwen Hunter<\/strong>\u00a0\u2013 Director, Stem Cell Biology, Research &amp; Development, STEMCELL Technologies\u00a0<\/li>\n\n\n\n<li><strong>Michael Kennedy<\/strong>\u00a0\u2013 Director, AbCellera\u00a0<\/li>\n\n\n\n<li><strong>Cassandra<\/strong>\u00a0<strong>Kinch\u00a0<\/strong>\u2013 SVP, Asset Development, Stream Neuroscience Inc.\u00a0<\/li>\n\n\n\n<li><strong>Yussanne<\/strong>\u00a0<strong>Ma\u00a0<\/strong>\u2013 Director of Operations, Canada&#8217;s Michael Smith Genome Sciences Centre\u00a0<\/li>\n\n\n\n<li><strong>Megan<\/strong>\u00a0<strong>Mahoney\u00a0<\/strong>\u2013 Director of Scientific Affairs &amp; Training, BioCanRx\u00a0<\/li>\n\n\n\n<li><strong>Serena Mandla<\/strong>\u00a0\u2013 CSO &amp; Co-Founder, Noa Therapeutics\u00a0<\/li>\n\n\n\n<li><strong>Polina Martins<\/strong>\u00a0\u2013 Senior Director, Communications, Public Affairs &amp; People Strategy, Ontario Genomics\u00a0<\/li>\n\n\n\n<li><strong>Scott McAuley,\u00a0<\/strong>\u2013 Head of Research &amp; Equity Research Analyst, Healthcare &amp; Biotechnology, Paradigm Capital\u00a0<\/li>\n\n\n\n<li><strong>Cory Mulvihill<\/strong>\u00a0\u2013 Associate Vice President, Strategy &amp; External Affairs, Centre for Probe Development and Commercialization (CPDC)\u00a0<\/li>\n\n\n\n<li><strong>Claudie<\/strong>\u00a0<strong>No\u00ebl\u00a0<\/strong>\u2013 Senior Director, Operations, Montr\u00e9al InVivo\u00a0<\/li>\n\n\n\n<li><strong>Marc Shenouda<\/strong>\u00a0\u2013 CEO, Neuropeutics Inc.\u00a0<\/li>\n\n\n\n<li><strong>Chen Wan<\/strong>\u00a0\u2013 Director, Research &amp; Innovation, Health, Genome BC\u00a0<\/li>\n\n\n\n<li><strong>Conrad Winters<\/strong>\u00a0\u2013 VP, CMC, Ventus Therapeutics\u00a0<\/li>\n\n\n\n<li><strong>Christina Yeh<\/strong>\u00a0\u2013 Vice President, Programs &amp; Strategic Partnerships, OBIO<\/li>\n<\/ul>\n\n\n\n<p>The Executive Institute is one of a suite of talent development programs that adMare delivers and supports. Alongside ASCEND, and the Biotechnology Industry Skills (BIS) program and biomanufacturing training initiatives delivered by CASTL, adMare helps build the technical, leadership and company-building talent required to translate scientific discoveries into innovative products, globally competitive companies and economic growth.<\/p>\n\n\n\n<p>To learn more about how the Executive Institute is building the next generation of life sciences leaders in Canada, visit:&nbsp;<a href=\"https:\/\/admarebio.com\/en\/building-companies\/talent-development\/\">Talent Development | adMare<\/a><\/p>\n\n\n\n<p>-30-<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Twenty-two leaders from across Canada\u2019s life sciences sector join adMare\u2019s flagship leadership development program to strengthen the leadership pipeline driving company creation and growth.&nbsp; Vancouver (BC), Toronto (ON), and Montreal [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":2730,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28],"tags":[],"company":[],"class_list":["post-2729","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-admare-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0 | adMare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/admarebio.com\/en\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0 | adMare\" \/>\n<meta property=\"og:description\" content=\"Twenty-two leaders from across Canada\u2019s life sciences sector join adMare\u2019s flagship leadership development program to strengthen the leadership pipeline driving company creation and growth.&nbsp; Vancouver (BC), Toronto (ON), and Montreal [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/\" \/>\n<meta property=\"og:site_name\" content=\"adMare\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-24T18:35:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/09\/Annonce.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Earnscliffe Strategies\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Earnscliffe Strategies\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/\"},\"author\":{\"name\":\"Earnscliffe Strategies\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/person\\\/bd78e975574bdbf66541602c00a312da\"},\"headline\":\"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0\",\"datePublished\":\"2026-09-24T18:35:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/\"},\"wordCount\":611,\"publisher\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Annonce.png\",\"articleSection\":[\"adMare News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/\",\"name\":\"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0 | adMare\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Annonce.png\",\"datePublished\":\"2026-09-24T18:35:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Annonce.png\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Annonce.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News &#038; Events\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News &#038; Insights\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\",\"name\":\"adMare\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admarebio.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\",\"name\":\"adMare\",\"url\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"width\":915,\"height\":337,\"caption\":\"adMare\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/person\\\/bd78e975574bdbf66541602c00a312da\",\"name\":\"Earnscliffe Strategies\",\"url\":\"#\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0 | adMare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/","og_locale":"en_US","og_type":"article","og_title":"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0 | adMare","og_description":"Twenty-two leaders from across Canada\u2019s life sciences sector join adMare\u2019s flagship leadership development program to strengthen the leadership pipeline driving company creation and growth.&nbsp; Vancouver (BC), Toronto (ON), and Montreal [&hellip;]","og_url":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/","og_site_name":"adMare","article_published_time":"2026-09-24T18:35:50+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/09\/Annonce.png","type":"image\/png"}],"author":"Earnscliffe Strategies","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Earnscliffe Strategies","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/#article","isPartOf":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/"},"author":{"name":"Earnscliffe Strategies","@id":"https:\/\/admarebio.com\/en\/#\/schema\/person\/bd78e975574bdbf66541602c00a312da"},"headline":"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0","datePublished":"2026-09-24T18:35:50+00:00","mainEntityOfPage":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/"},"wordCount":611,"publisher":{"@id":"https:\/\/admarebio.com\/en\/#organization"},"image":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/#primaryimage"},"thumbnailUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/09\/Annonce.png","articleSection":["adMare News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/","url":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/","name":"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0 | adMare","isPartOf":{"@id":"https:\/\/admarebio.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/#primaryimage"},"image":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/#primaryimage"},"thumbnailUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/09\/Annonce.png","datePublished":"2026-09-24T18:35:50+00:00","breadcrumb":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/#primaryimage","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/09\/Annonce.png","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/09\/Annonce.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-ix-of-the-executive-institute\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admarebio.com\/en\/"},{"@type":"ListItem","position":2,"name":"News &#038; Events","item":"https:\/\/admarebio.com\/en\/news-events\/"},{"@type":"ListItem","position":3,"name":"News &#038; Insights","item":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/"},{"@type":"ListItem","position":4,"name":"adMare BioInnovations Welcomes Cohort IX of the Executive Institute\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/admarebio.com\/en\/#website","url":"https:\/\/admarebio.com\/en\/","name":"adMare","description":"","publisher":{"@id":"https:\/\/admarebio.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admarebio.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/admarebio.com\/en\/#organization","name":"adMare","url":"https:\/\/admarebio.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admarebio.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","width":915,"height":337,"caption":"adMare"},"image":{"@id":"https:\/\/admarebio.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/admarebio.com\/en\/#\/schema\/person\/bd78e975574bdbf66541602c00a312da","name":"Earnscliffe Strategies","url":"#"}]}},"_links":{"self":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts\/2729","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/comments?post=2729"}],"version-history":[{"count":1,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts\/2729\/revisions"}],"predecessor-version":[{"id":2731,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts\/2729\/revisions\/2731"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/media\/2730"}],"wp:attachment":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/media?parent=2729"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/categories?post=2729"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/tags?post=2729"},{"taxonomy":"company","embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/company?post=2729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}